Autopsy report · NCT01648712

Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery

“for difficulty to enroll patients in the study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 2 years 1 month before it stopped.
• 48 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Hôpital Necker-Enfants Malades

Sponsor type

University, hospital or other

Conditions

Acquired Platelet Function Disorder

Interventions

Balance surface, Carmeda heparin-coated surface; non -heparin extracorporeal pediatric device for operation

Participants

48

Sites

1

Countries

France

Trials that died the same way

• Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
  “difficulty of enrolling patients” (87% match in meaning)
• Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease
  “due to the difficulty to enroll suitable patients” (86% match in meaning)
• Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer
  “Difficulty in enrolling patients” (85% match in meaning)
• Non-Contrast Magnetic Resonance Angiography Assessment of Patients Referred for Transcatheter Aortic Valve Implantation
  “Difficulty enrolling patients” (83% match in meaning)
• Extended vs Flexed Elbow Casting
  “Study team had difficulties recruiting and enrolling patients into this study.” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.